Literature DB >> 16615657

Estimating causal effects from multiple cycle data in studies of in vitro fertilization.

Joseph W Hogan1, Daniel O Scharfstein.   

Abstract

Prospective studies of reproductive outcomes frequently record data at multiple cycles. For example, studies of in vitro fertilization and embryo transfer (IVF-ET) follow women or couples for possibly several IVF cycles and record outcomes such as pregnancy status and embryo implantation. Several time-varying covariates, such as age and diagnostic markers, typically are available as well. When attention is focused on measurement of exposure effects, the use of multiple cycle data poses several complications. If the study is observational, the exposure probability may depend on subject characteristics. Moreover, attrition rates in IVF-ET can be substantial, and the attrition process can be expected to depend heavily on prior outcome. In fact, both success (pregnancy) and failure (lack of embryo implantations) can be prognostic of dropout. In this paper, we illustrate the use of causal modeling for multiple cycle data. Key assumptions are reviewed, and inference based on weighted estimating equations is described in detail. The methods are applied to a study of the effects of hydrosalpinx among women with tubal disease undergoing IVF-ET.

Entities:  

Mesh:

Year:  2006        PMID: 16615657     DOI: 10.1191/0962280206sm439oa

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  2 in total

1.  IVF success corrected for drop-out: use of inverse probability weighting.

Authors:  Anna M Modest; Lauren A Wise; Matthew P Fox; Jennifer Weuve; Alan S Penzias; Michele R Hacker
Journal:  Hum Reprod       Date:  2018-12-01       Impact factor: 6.918

2.  Predicting cumulative live birth for couples beginning their second complete cycle of in vitro fertilization treatment.

Authors:  Mariam B Ratna; Siladitya Bhattacharya; N van Geloven; David J McLernon
Journal:  Hum Reprod       Date:  2022-08-25       Impact factor: 6.353

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.